EDITORIAL
Published on 11 Sep 2020
Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
doi 10.3389/fphar.2020.593822
- 2,843 views
- 28 citations
- Frontiers in Pharmacology
- Neuropharmacology
- Research Topics
- Non-Dopaminergic Systems in Parkinson’s Disease
Non-Dopaminergic Systems in Parkinson’s Disease
26k
Total Downloads
117k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 23 Apr 2020
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
doi 10.3389/fphar.2020.00356
- 63,696 views
- 266 citations
REVIEW
Published on 08 Apr 2020
The Noradrenergic System in Parkinson’s Disease
doi 10.3389/fphar.2020.00435
- 14,664 views
- 91 citations
ORIGINAL RESEARCH
Published on 20 Mar 2020
Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
doi 10.3389/fphar.2020.00304
- 2,265 views
- 6 citations
REVIEW
Published on 29 Jan 2020
Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
doi 10.3389/fnins.2020.00025
- 11,261 views
- 36 citations
MINI REVIEW
Published on 15 Jan 2020
Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease
doi 10.3389/fphar.2019.01494
- 5,971 views
- 36 citations
PERSPECTIVE
Published on 13 Dec 2019
Striatal Cholinergic Interneurons: How to Elucidate Their Function in Health and Disease
doi 10.3389/fphar.2019.01488
- 13,062 views
- 34 citations
REVIEW
Published on 27 Nov 2019
Sleep Disorders in Rodent Models of Parkinson’s Disease
doi 10.3389/fphar.2019.01414
- 6,610 views
- 28 citations
MINI REVIEW
Published on 30 Oct 2019
Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s Disease
doi 10.3389/fphar.2019.01294
- 5,986 views
- 35 citations
ORIGINAL RESEARCH
Published on 25 Oct 2019
Knock-Down of GPR88 in the Dorsal Striatum Alters the Response of Medium Spiny Neurons to the Loss of Dopamine Input and L-3-4-Dyhydroxyphenylalanine
doi 10.3389/fphar.2019.01233
- 2,263 views
- 8 citations
MINI REVIEW
Published on 03 Oct 2019
l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease
doi 10.3389/fphar.2019.01119
- 7,391 views
- 26 citations
Published in
Frontiers in Pharmacology
- Neuropharmacology
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore
Impact
- 117kTopic views
- 87kArticle views
- 26kArticle downloads